glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Plasma Cell Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, H; Inoue, R; Katagiri, S; Kitani, T; Shibayama, H; Tagawa, S | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Plasma Cell Tumor
| Article | Year |
|---|---|
Laminin and fibronectin promote the chemotaxis of human malignant plasma cell lines.
Topics: Antibodies, Monoclonal; Cell Adhesion; Cell Size; Chemotaxis; Fibronectins; Humans; Laminin; Neoplasm Proteins; Neoplastic Stem Cells; Oligopeptides; Plasma Cells; Plasmacytoma; Receptors, Fibronectin; Receptors, Laminin; Receptors, Very Late Antigen; Tumor Cells, Cultured | 1995 |